Circulating NETs enable early identification of thrombotic risk in sepsis at emergency care onset

循环中的中性粒细胞胞外陷阱(NETs)有助于在急诊护理初期早期识别脓毒症患者的血栓风险。

阅读:2

Abstract

INTRODUCTION: Sepsis involves a dysregulated host response to infection and is frequently complicated by coagulopathy, contributing to organ dysfunction and mortality. Early detection of coagulation disturbances in the emergency department (ED) remains clinically challenging. Neutrophil extracellular traps (NETs) have emerged as key mediators linking inflammation and thrombosis in sepsis, yet their prognostic value during early care is unclear. This study aimed to assess whether circulating NETs measured at sepsis onset are associated with inflammatory biomarkers, sepsis-induced coagulopathy (SIC) status, and clinical outcomes. METHODS: We conducted a retrospective study including 212 adult patients with sepsis recruited at the ED presentation. Plasma NETs, IL-6, and MR-ProADM were measured by ELISA. The ISTH SIC score was used to identify early-stage coagulopathy. RESULTS: Circulating NETs were detected in 61 patients (28.8%) and higher NETs levels were significantly associated with elevated D-dimer, LDH, IL-6, PCT, and hypocholesterolemia. NETs positive patients had increased odds of positive blood cultures (OR = 2.3; 95% CI: 1.2-2.5), thromboembolic events (OR = 4.4; 95% CI: 1.0-19.0), and SOFA ≥ 5 (OR = 2.0; 95% CI: 1.1-2.9). Among 202 patients with complete data to SIC evaluation, 49% met SIC criteria. Although NETs were not independently associated with SIC, their inflammatory and clinical impact was significantly amplified in SIC-positive patients, suggesting a synergetic interaction between NETosis and early coagulopathy. DISCUSSION: NETs quantification at ED presentation may help identify a high-risk immunothrombotic phenotype in sepsis and support earlier NETosis-targeted therapies alongside anticoagulation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。